E. Atağ Et Al. , "Risk Adaptive Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer," UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , vol.16, no.2, pp.57-62, 2017
Atağ, E. Et Al. 2017. Risk Adaptive Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer. UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , vol.16, no.2 , 57-62.
Atağ, E., Karaoğlu, A., & Küçük, Ö., (2017). Risk Adaptive Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer. UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , vol.16, no.2, 57-62.
Atağ, Elif, AZİZ KARAOĞLU, And Ömer Küçük. "Risk Adaptive Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer," UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , vol.16, no.2, 57-62, 2017
Atağ, Elif Et Al. "Risk Adaptive Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer." UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , vol.16, no.2, pp.57-62, 2017
Atağ, E. Karaoğlu, A. And Küçük, Ö. (2017) . "Risk Adaptive Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer." UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY , vol.16, no.2, pp.57-62.
@article{article, author={Elif Atağ Et Al. }, title={Risk Adaptive Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer}, journal={UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY}, year=2017, pages={57-62} }